Literature DB >> 9450578

Irinotecan-related cholinergic syndrome induced by coadministration of oxaliplatin.

J Valencak, M Raderer, G V Kornek, M H Henja, W Scheithauer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9450578     DOI： 10.1093/jnci/90.2.160

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  4 in total

1.  Irinotecan-induced dysarthria: an insight into its pathogenesis?

Authors:  Jesus A Gomez; Ines Sanchez; Jose A Ramirez
Journal:  Gastrointest Cancer Res       Date:  2008-07

Review 2.  Oxaliplatin. A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies.

Authors:  C R Culy; D Clemett; L R Wiseman
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546

3.  Ternary combination of irinotecan, fluorouracil-folinic acid and oxaliplatin: results on human colon cancer cell lines.

Authors:  J L Fischel; P Rostagno; P Formento; A Dubreuil; M C Etienne; G Milano
Journal:  Br J Cancer       Date:  2001-02       Impact factor: 7.640

Review 4.  Standardization of the infusion sequence of antineoplastic drugs used in the treatment of breast and colorectal cancers.

Authors:  Amanda Alves da Silva; Juliane Carlotto; Inajara Rotta
Journal:  Einstein (Sao Paulo)       Date:  2018-06-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.